Trichomonosis, a Common Curable STI, and Prostate Carcinogenesis-A Proposed Molecular Mechanism

PLoS Pathogens

Volumn 8, Issue 8, 2012, Pages

  Sutcliffe, Siobhan ^a   Neace, Calvin ^b   Magnuson, Nancy S ^b   Reeves, Raymond ^b   Alderete, J F ^b  

^a Washington University in St Louis School of Medicine   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HIGH MOBILITY GROUP A1A PROTEIN; PROTEIN KINASE PIM 1;

CANCER EPIDEMIOLOGY; CARCINOGENESIS; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; PROSTATE CANCER; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS;

EID: 84866175990     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002801     Document Type: Review

References (28)

1. Hobbs MM, Sena AC, Swygard H, Schwebke JR. (2008) Trichomonas vaginalis and trichomoniasis. In: Sexually transmitted diseases. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, editors. Sexually transmitted diseases. New York: McGraw-Hill Medical. 771-793.
2. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
3. Mitteregger D, Aberle SW, Makristathis A, Walochnik J, Brozek W, et al. (2012) High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue. Med Microbiol Immunol 201: 113-116.
4. Gardner WA, Culberson DE, Bennett BD, (1986) Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 110: 430-432.
5. Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor A, et al. (2009) Trichomonas vaginalis infection and prostate cancer incidence and mortality: a prospective study in the physician's health study. J Natl Cancer Inst 101: 1-6.
6. Sutcliffe S, Giovannucci E, Alderete JF, Chang TH, Gaydos, et al. (2006) Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15: 939-945.
7. Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, et al. (2009) Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Intl J Cancer 124: 2082-2087.
8. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, et al. (2007) Inflammation in prostate carcinogenesis. Nature Rev Cancer 7: 256-269.
9. Diana F, Di Bernardo J, Sgarra R, Tessari MA, Rustighi A, et al. (2005) Differential HMGA expression and post-translational modifications in prostate tumor cells. Int J Oncol 26: 515-520.
10. Shah N, Pang B, Yeoh KG, Thorn S, Chen CS, et al. (2008) Potential roles for the PIM1 kinase in human cancer-a molecular and therapeutic appraisal. Eur J Cancer 44: 2144-2151.
11. Valdman A, Fang X, Pang ST, Ekman P, Egevad L, (2004) PIM1 expression in prostatic intraepithelial neoplasia and human prostate cancer. Prostate 60: 367-371.
12. Wang J, Kim J, Franco OE, Hayward SW, Wills ML, et al. (2010) Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene 29: 2477-2487.
13. Kucknoor AS, Mundodi V, Alderete JF, (2007) The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cell Microbiol 9: 2586-2597.
14. Ryu JS, Kang JH, Jung SY, Shin MH, Kim JM, et al. (2004) Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect Immun 72: 1326-1332.
15. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, et al. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826.
16. Han IH, Park SJ, Ahn MH, Ryu JS, (2012) Involvement of mast cells in inflammation induced by Trichomonas vaginalis via crosstalk with vaginal epithelial cells. Parasite Immunol 34: 8-14.
17. Azevedo A, Cunha V, Teixeira AL, Medeiros R, (2011) IL-6/IL6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol 2: 384-396.
18. Stark JR, Li H, Kraft P, Giovannucci EL, Stampfer M, et al. (2009a) Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer 124: 2683-2689.
19. Magnuson NS, Wang Z, Ding G, Reeves R, (2010) Why target PIM1 for cancer diagnosis and treatment? Future Oncol 6: 1461-1478.
20. Roh M, Franco OE, Hayward SW, van der Meer R, Abdulkadir SA, (2008) A role for polyploidy in the tumorigenicity of PIM1-expressing human prostate and mammary epithelial cells. PLoS ONE 3: e2572 doi:10.1371/journal.pone.0002572.
21. Sansone P, Bromberg J, (2012) Targeting the interleukin-6/jak/stat pathway in human malignancies. J Clin Oncol 30: 1005-1014.
22. Reeves R, Beckerbauer L, (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519: 13-29.
23. Zhang Y, Wang Z, Li X, Magnuson NS, (2008) Pim-1 kinase-dependent inhibition of c-MYC degradation. Oncogene 27: 4809-4819.
24. Hillion J, Dhara S, Sumter TF, Mukherjee M, Di Cello F, et al. (2008) The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an Achilles heel for hematopoietic malignancies? Cancer Res 68: 10121-10127.
25. Tesfaye A, Di Cello F, Hillion J, Ronnett BM, Elbahloul O, et al. (2007) The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res 67: 3998-4004.
26. Cowan MJ, Coll T, Shelhamer JH, (2006) Polyamine-mediated reduction in human airway epithelial migration in response to wounding is PGE2 dependent through decreases in COX-2 and cPLA2 protein levels. J Appl Physiol 101: 1127-1135.
27. Garcia A, Benchimol M, Alderete JF, (2005) Trichomonas vaginalis polyamine metabolism is linked to host cell adherence and cytotoxicity. Infect Immun 73: 2602-2610.
28. Hu XF, Li J, Vandervalk S, Wang Z, Magnuson NS, et al. (2009) PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest 119: 362-375.